Expression and prognostic analyses of the insulin-like growth factor 2 mRNA binding protein family in human pancreatic cancer
Abstract Background Despite advances in early diagnosis and treatment, cancer remains the leading cause of mortality worldwide. The insulin-like growth factor 2 mRNA binding protein (IGF2BP) family has been reported to be involved in a variety of human malignant tumours. However, little is known abo...
Main Authors: | Xiao-Han Cui, Shu-Yi Hu, Chun-Fu Zhu, Xi-Hu Qin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-020-07590-x |
Similar Items
-
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer
by: Hung-Ming Chen, et al.
Published: (2021-06-01) -
Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer
by: Xinwei Huang, et al.
Published: (2018-06-01) -
RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
by: Markus Glaß, et al.
Published: (2020-06-01) -
Expression and characterization of insulin-like growth factor II mRNA binding protein in the razor clam Sinonovacula constricta
by: Shumei Xie, et al.
Published: (2017-11-01) -
Insulin-Like Growth Factor 2 mRNA-Binding Protein 3 Modulates Aggressiveness of Ewing Sarcoma by Regulating the CD164-CXCR4 Axis
by: Caterina Mancarella, et al.
Published: (2020-07-01)